Gelteq (GELS) Short term Debt (2023 - 2025)
Gelteq (GELS) posted quarterly Short term Debt of $2.7 million for Q2 2025, up 96.02% year-over-year from $1.4 million in Q2 2024, and up 6.03% quarter-over-quarter from $2.5 million in Q4 2024.
Gelteq (GELS) Short term Debt (2023 - 2025) Analysis & Trends
Gelteq's Short term Debt history runs 3 years deep, the most recent figure standing at $2.7 million for Q2 2025.
- In Q2 2025, Short term Debt rose 96.02% year-over-year to $2.7 million; the TTM figure through Jun 2025 stood at $2.7 million (up 96.02% YoY), while the FY2025 annual figure was $2.7 million, up 96.02% from the prior year.
- Short term Debt for Q2 2025 stood at $2.7 million, up from $2.5 million in the prior quarter.
- The five-year high for Short term Debt was $2.7 million in Q2 2025, with the low at $3399.3 in Q2 2023.
- The 3-year median for Short term Debt is $2.0 million (2024), against an average of $1.7 million.
- The sharpest annual moves came in 2024 and 2025: Short term Debt surged 40305.81% in 2024, then soared 96.02% in 2025.
- Gelteq's Short term Debt stood at $3399.3 in 2023, then soared by 74597.21% to $2.5 million in 2024, then gained by 6.03% to $2.7 million in 2025.
- Business Quant data shows GELS's Short term Debt at $2.7 million in Q2 2025, $2.5 million in Q4 2024, and $1.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Gelteq | 5.90 Mn | 5.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Jun 30, 2023 | 3,399.28 |